文献速递中毒与环境急症消化、代谢与肾脏急症

处方阿片类药物与苯二氮䓬类药物联用与药物过量的关联:回顾性分析

Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis.
PubMed 文献 · BMJ · 2017-03-14
一句话结论2001至2013年美国私人保险阿片使用者中苯二氮䓬联用率从9%升至17%,联用与阿片过量急诊或住院风险升高相关(aOR 2.14)。

该回顾性分析利用2001-2013年美国行政理赔数据库,纳入315428名连续参保且至少配过一次阿片处方的18-64岁私人保险人群,定义苯二氮䓬/阿片联用为两药处方覆盖时间至少重叠一天。阿片使用者中联用苯二氮䓬的比例从2001年的9%升至2013年的17%(相对增加80%),该增长主要由间歇性而非慢性阿片使用者驱动。与未联用苯二氮䓬的阿片使用者相比,联用者因阿片过量急诊就诊或住院的风险升高(全体aOR 2.14,95%CI 2.05-2.24;间歇性aOR 1.42,95%CI 1.33-1.51;慢性aOR 1.81,95%CI 1.67-1.96)。若该关联为因果,消除联用估计可减少15%(95%CI 14-16)的阿片相关急诊就诊和过量住院。

要点

  • 2001至2013年,阿片使用者中联用苯二氮䓬的比例从9%升至17%,相对增加80%。
  • 联用苯二氮䓬的阿片使用者因阿片过量急诊或住院的风险升高(全体aOR 2.14,95%CI 2.05-2.24)。
  • 间歇性阿片使用者联用苯二氮䓬的过量急诊或住院aOR为1.42(95%CI 1.33-1.51)。
  • 慢性阿片使用者联用苯二氮䓬的过量急诊或住院aOR为1.81(95%CI 1.67-1.96)。
  • 若关联为因果,消除联用估计可减少15%(95%CI 14-16)的阿片相关急诊和过量住院。

适用人群与场景

  • 2001-2013年期间连续参加美国私人保险计划、具有医疗和药房福利、年龄18-64岁且至少配过一次阿片处方的315428人。

诊断标准与关键阈值

  • 苯二氮䓬/阿片联用定义为两种药物处方覆盖的时间段至少重叠一天。

研究设计与关键结果

  • 研究类型为行政理赔数据的回顾性分析,样本量315428人,时间范围2001-2013年。
  • 阿片使用者中联用苯二氮䓬的比例从2001年的9%升至2013年的17%,相对增加80%,增长主要由间歇性阿片使用者驱动。
  • 与未联用苯二氮䓬的阿片使用者相比,联用者因阿片过量急诊就诊或住院的校正比值比为2.14(95%CI 2.05-2.24;P<0.001)。
  • 间歇性阿片使用者联用苯二氮䓬的校正比值比为1.42(95%CI 1.33-1.51;P<0.001),慢性阿片使用者为1.81(95%CI 1.67-1.96;P<0.001)。
  • 若关联为因果,消除联用估计可减少15%(95%CI 14-16)的阿片相关急诊就诊和过量住院。

证据类型、等级与局限

  • 证据类型:回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,若该关联为因果,消除苯二氮䓬/阿片联用估计可减少15%(95%CI 14-16)的阿片相关急诊就诊和过量住院。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Objectives To identify trends in concurrent use of a benzodiazepine and an opioid and to identify the impact of these trends on admissions to hospital and emergency room visits for opioid overdose.Design Retrospective analysis of claims data, 2001-13.Setting Administrative health claims database.Participants 315 428 privately insured people aged 18-64 who were continuously enrolled in a health plan with medical and pharmacy benefits during the study period and who also filled at least one prescription for an opioid.Interventions Concurrent benzodiazepine/opioid use, defined as an overlap of at least one day in the time periods covered by prescriptions for each drug. Main outcome measures Annual percentage of opioid users with concurrent benzodiazepine use; annual incidence of visits to emergency room and inpatient admissions for opioid overdose.Results 9% of opioid users also used a benzodiazepine in 2001, increasing to 17% in 2013 (80% relative increase). This increase was driven mainly by increases among intermittent, as opposed to chronic, opioid users. Compared with opioid users who did not use benzodiazepines, concurrent use of both drugs was associated with an increased risk of an emergency room visit or inpatient admission for opioid overdose (adjusted odds ratio 2.14, 95% confidence interval 2.05 to 2.24; P<0.001) among all opioid users. The adjusted odds ratio for an emergency room visit or inpatient admission for opioid overdose was 1.42 (1.33 to 1.51; P<0.001) for intermittent opioid users and 1.81 (1.67 to 1.96; P<0.001) chronic opioid users. If this association is causal, elimination of concurrent benzodiazepine/opioid use could reduce the risk of emergency room visits related to opioid use and inpatient admissions for opioid overdose by an estimated 15% (95% confidence interval 14 to 16).Conclusions From 2001 to 2013, concurrent benzodiazepine/opioid use sharply increased in a large sample of privately insured patients in the US and significantly contributed to the overall population risk of opioid overdose.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Sun EC, Dixit A, Humphreys K, et al. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ. 2017. PMID: 28292769. doi:10.1136/bmj.j760

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。